Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Classement en actions
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Prix de l'action
$3.40
Capitalisation boursière
$9.07B
Changement (1 jour)
-1.61%
Changement (1 an)
-16.08%
Pays
CN
Échange Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Catégorie
Healthcare
Revenus pour Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Revenus en Oct 2026 TTM : 0
Selon les derniers rapports financiers de Shanghai Fosun Pharmaceutical (Group) Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Shanghai Fosun Pharmaceutical (Group) Co., Ltd. de 2001 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2025 | $5.93B | 5.44% |
| 2024 | $5.63B | -3.80% |
| 2023 | $5.85B | -8.21% |
| 2022 | $6.37B | 3.81% |
| 2021 | $6.14B | 32.30% |
| 2020 | $4.64B | 13.01% |
| 2019 | $4.11B | 13.32% |
| 2018 | $3.62B | 27.17% |
| 2017 | $2.85B | 35.20% |
| 2016 | $2.11B | 8.52% |
| 2015 | $1.94B | 0.01% |
| 2014 | $1.94B | 17.81% |
| 2013 | $1.65B | 39.99% |
| 2012 | $1.18B | 14.43% |
| 2011 | $1.03B | 49.06% |
| 2010 | $690.17M | 22.38% |
| 2009 | $563.96M | 1.99% |
| 2008 | $552.97M | 9.32% |
| 2007 | $505.81M | -3.27% |
| 2006 | $522.92M | 41.24% |
| 2005 | $370.24M | 27.18% |
| 2004 | $291.11M | 11.82% |
| 2003 | $260.35M | 108.87% |
| 2002 | $124.64M | 41.71% |
| 2001 | $87.96M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
